Fangda Partners, Capital Markets: Debt & Equity (PRC Firms) | Chambers Greater China Region Profile

About

Provided by Fangda Partners

We are recognized by the market to be one of the go-to firms for handling the most complicated and high-profile A-share IPOs, material assets restructurings and public M&A. We have extensive experience in international equity and debt offerings, including IPOs, follow-on offerings, H-share convertible issuance and corporate bonds issuance (both investment grade and high-yield). We continue to serve a host of leading TMT and internet companies, as well as healthcare and biotech companies.

Equity Capital Markets
We handle the most complex and high-profile A-share initial public offerings in our market. Our team is viewed as the market leader in this field, ranking highly in substantially all of the leading legal benchmark publications focused on China.

Debt Capital Markets
Our debt capital markets team leads work on a full range of debt securities offerings and related transactions, advising clients on corporate bonds issuance (both high-yield and investment grade); on the establishment of, updates to, and drawdowns under debt issuance programs; on tender offers, exchange offers and other liability management transactions; on preference shares, perpetual bonds and other hybrid securities offerings; on private placement of debt securities; as well as advising on Panda bond offerings.

Chambers Review

Provided by Chambers

Capital Markets: Hong Kong and Overseas Issuances - China

Band 3

What the Team is Known For

Fangda Partners is a solid corporate practice with extensive experience in overseas equity and debt offerings, including IPOs and H-share convertible issuances. It is known for advising on listings in the USA, Singapore and Hong Kong. The team is equipped to handle corporate bond, perpetual bond and panda bond issuances. Fangda Partners continues to serve a host of leading pharmaceutical, biotech and internet companies, as well as financial institutions. The law firm is active in representing both issuers and underwriters in the domestic market, especially with regard to companies delisted from overseas markets returning to the domestic market.

业务优势

方达律师事务所业务扎实的公司法团队拥有广泛的海外股票和债券发行经验, 包括首次公开招股和H股可转换股发行。该律所以为美国、新加坡和香港上市提供法律意见而著称。该团队具备办理公司债券、永续债券和熊猫债券发行的业务能力。方达继续为领先的制药、生物科技、互联网公司和金融机构提供服务。该律所活跃于在国内市场代表发行人和承销商，对处理公司从海外市场退市回归国内资本市场表现尤为出色。

View ranking table

Work Highlights

Provided by Fangda Partners

Fangda Partners advised Gambol Pet Group on its listing on the ChiNext Board of the Shenzhen Stock Exchange.
Fangda acted for QuantumPharm on its IPO on the Main Board of the Hong Kong Stock Exchange.
方达为晶泰科技在港交所主板的首次公开发行提供法律服务。
方达律师事务所为乖宝宠物食品集团股份有限公司在深圳证券交易所创业板上市提供法律服务。